The Technical AnalystExchange: STO Sector: Financial Services Industry: Asset Management
MedCap AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.99% SEK508.00
America/New_York / 17 mai 2024 @ 11:29
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 7 522.16 mill |
| EPS: | 11.60 |
| P/E: | 43.79 |
| Earnings Date: | Aug 13, 2024 |
| SharesOutstanding: | 14.81 mill |
| Avg Daily Volume: | 0.0179 mill |
| RATING 2024-05-17 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 43.79 | sector: PE -60.04 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 43.79 | industry: PE -26.91 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SEK489.00 (-3.74%) SEK-19.00 |
| Date: 2024-05-18 |
| Expected Trading Range (DAY) |
|---|
|
SEK 495.60 - 520.41 ( +/- 2.44%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SEK508.00 (0.99% ) |
| Volume | 0.0111 mill |
| Avg. Vol. | 0.0179 mill |
| % of Avg. Vol | 61.93 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MCAP.ST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MCAP.ST
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.